Osman Serhat Tokgöz

Osman Serhat Tokgöz

Auto-generated profile, based on publicly available information

Osman Serhat Tokgöz

Department of Neurology , Necmettin Erbakan University Faculty of Medicine , Konya , Türkiye

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
STSerhat Tokgoz
Serhat Tokgoz
MKMehmet Kayrak
Mehmet Kayrak
ZAZehra Akpinar
Zehra Akpinar
ASAbdullah Seyithanoğlu
Abdullah Seyithanoğlu
FGFigen Güney
Figen Güney
BYBetigül Yürüten
Betigül Yürüten

1 September 2014 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
STSerhat Tokgoz
Serhat Tokgoz
SKSuat Keskin
Suat Keskin
MKMehmet Kayrak
Mehmet Kayrak
ASAbdullah Seyithanoglu
Abdullah Seyithanoglu
AOAysegul Ogmegul
Aysegul Ogmegul

14 December 2012 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
STSerhat Tokgoz
Serhat Tokgoz
AZAyse Gul Zamani
Ayse Gul Zamani
HDHatice Gul Durakbasi-Dursun
Hatice Gul Durakbasi-Dursun
OYOsman Yılmaz
Osman Yılmaz
NINurhan Ilhan
Nurhan Ilhan
ASAlper Sinan
Alper Sinan

1 January 2025 in Sao Paulo Medical Journal
Verified
Journal Article
Open access
STSefa Tatar
Sefa Tatar
OTOsman Serhat Tokgöz
Osman Serhat Tokgöz
ÜSÜmmü Gülsüm Selvi
Ümmü Gülsüm Selvi
BACKGROUND: The atherogenic index of plasma (AIP), derived from the logarithmic transformation of the triglyceride to high-density lipoprotein cholesterol ratio, is frequently used to predict cardiovascular events. OBJECTIVE: This study aimed to investigate the association between AIP and 1-month mortality in patients with acute ischemic stroke (AIS). DESIGN AND SETTING: Retrospective study was conducted in Türkiye. METHODS: In total, 530 AIS patients were enrolled in this study. Clinical, demographic, and laboratory characteristics were recorded within 24 hours of admission. One-month mortality outcomes were analyzed in relation to the AIP of the patients. RESULTS: Of the 530 patients, 140 patients did not survive during the follow-up period. The mean AIP was 0.50 ± 0.33 in survivors and 0.11 ± 0.27 in the mortality group (P = 0.001). In the receiver operating characteristic analysis, the AIP value of 0.291 had a sensitivity of 74.4%, specificity of 76.4%, positive predictive value of 75.92%, and negative predictive value of 74.9% for mortality. The AIP value above 0.291 had an AUC (area under curve) of 0.829 (95% CI [confidence interval] 0.78–0.88, P = 0.0001). In Cox regression analysis, AIP values below 0.291 (HR 3.962; 95% CI 2.643–5.937) were identified as an independent predictor of mortality. Higher mortality rates were observed in patients with cryptogenic stroke and AIP below 0.291 after stratification by stroke TOAST (P = 0.003). CONCLUSIONS: Lower AIP is an independent predictor of short-term mortality in AIS patients, surpassing the sensitivity of traditional lipid parameters. This study provides a valuable prognostic tool for clinicians, offering a non-invasive and cost-effective test for a condition associated with substantial mortality and morbidity.

18 April 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
SASüleyman Ömer Anlıaçık
Süleyman Ömer Anlıaçık
STSerhat Tokgöz
Serhat Tokgöz
AZAyse Gul Zamani
Ayse Gul Zamani
MYMAHMUT SELMAN YILDIRIM
MAHMUT SELMAN YILDIRIM
MİMehmet Sinan İyisoy
Mehmet Sinan İyisoy
We aimed to investigate the associations between endothelial nitric oxide synthase(eNOS) gene polymorphisms [G894T (rs1799983)], intron 4 (27-bpTR) variable number tandem repeat (VNTR) and T786C (rs2070744), and ischemic stroke in the Anatolian population. This case-control study included 112 patients with “stroke of undetermined etiology” and 160 controls. Real-time polymerase chain reaction (RT-PCR) analysis was used to analyze these polymorphisms. Between-group frequencies of alleles and genotypes were compared using binary logistic regression analysis. No significant difference was observed between the two groups in terms of the genotype and allele distributions of the eNOS G894T (rs1799983) polymorphism (P > 0.05). The a alleles and the 4b/a and 4a/a genotypes of the intron 4 (27-bpTR) VNTR polymorphism had significantly higher frequencies in the patient group than in the control group (OR: 2.715, P < 0.001; OR: 3.396, P < 0.001; OR: 10.631, P = 0.016, respectively). On the contrary, the TC genotype and C alleles of the T786C (rs2070744) polymorphism had a significantly lower frequency in the patient group than in the control group (OR: 0.244, P < 0.001, OR: 0.605, P = 0.006, respectively) Our findings indicate that the eNOS G894T and T786C [rs2070744] polymorphisms are not associated with the risk of ischemic stroke, whereas the intron 4 [27-bpTR] VNTR may be a risk factor in the Anatolian population.

21 February 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
MAMustafa Altaş
Mustafa Altaş
AUAli Ulvi Uca
Ali Ulvi Uca
TATuran AKDAG
Turan AKDAG
FOFaruk Ömer Odabaş
Faruk Ömer Odabaş
OTOsman Serhat Tokgöz
Osman Serhat Tokgöz
Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative autoimmune chronic neurological disease. Currently, there are no effective serum biomarkers to verify MS diagnosis, to assess disease prognosis, and evaluate response to MS treatment. Objective: The present study is a preliminary assessment of irisin and nesfatin-1 serum levels in patients with relapsing- remitting MS (RRMS). Methods: A total of 86 participants, 42 patients with RRMS diagnosis and 44 healthy controls were included in the study. The serum irisin and nesfatin-1 parameters of the patients and control group members were analyzed. Results: Irisin and nesfatin-1 levels of the RRMS patients were significantly lower than the controls (z: -3.82, p<0.001; z: -4.79, p<0.001, respectively) The cut-off level of irisin is 10.390 (ng/mL) (sensitivity: 84.1%, specificity: 71.4%, AUC: 0.800), and the cut-off level of nestatin-1 is 7.155 (ng/mL) (sensitivity: 68.2%, specificity: 64.3%, AUC: 0.739) in the ROC analysis. For these cut-off levels in the case-control groups, the lower irisin and nesfatin-1 levels are the independent variables for MS patients (OR 9.723, 95%CI 2.884-32.785, p<0.001; OR 3.992, 95%CI 1.336-11.928, p<0.001) respectively. Conclusion: The present study revealed lower irisin and nesfatin-1 levels in patients with RRMS. These findings suggest that the decreased levels of irisin and nesfatin-1 peptides may contribute to MS pathogenesis such as inflammation, oxidative stress, and apoptosis in MS, leading to demyelination, axonal damage with neuronal loss, and gliosis.